Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming.

Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming.
J Cell Mol Med. 2020 Jun 09;:
Authors: Feng S, Zhang L, Liu X, Li G, Zhang B, Wang Z, Zhang H, Ma H
Abstract
AMP-activated protein kinase (AMPK) serves as a "supermetabolic regulator" that helps maintain cellular energy homeostasis. However, the role of AMPK in glucose metabolism reprogramming in lung cancer remains unclear. Here, our study shows that low AMPK expression correlates with metastasis and clinicopathologic parameters of non-small-cell lung cancer. Low AMPK significantly enhances the Warburg effect in HBE and A549 cells, which in turn induces the expression of mesenchymal markers and enhances their invasion and migration. At the mechanistic level, low AMPK up-regulates HK2 expression and glycolysis levels through HDAC4 and HDAC5. Collectively, our findings demonstrate that low AMPK-induced metabolism can promote epithelial-mesenchymal transition progression in normal bronchial epithelial cells and lung cancer cells, and increase the risk for tumour metastasis.
PMID: 32519437 [PubMed - as supplied by publisher]

Source: J Cell Mol Med - June 8, 2020 Category: Molecular Biology Authors: Feng S, Zhang L, Liu X, Li G, Zhang B, Wang Z, Zhang H, Ma H Tags: J Cell Mol Med Source Type: research